DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Phase III Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (CMX001 Adv).
Accessed April 3, 2021 at:
https://clinicaltrials.gov/ct2/show/NCT02087306
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.